Head-to-head · free

Regeneron Pharmaceuticals, Inc. vs Revolution Medicines, Inc.

REGN vs RVMD — return on capital, cash generation, margins and balance sheet side by side.

REGN

5 / 5

measures where REGN leads

RVMD

0 / 5

measures where RVMD leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureREGN · FY2025RVMD · FY2025
Revenue$14.3B$0
Net income$4.5B(1.1B)
Revenue growth (yearly, multi-year)-2.8%-37.2%
Free cash flow—(913.7M)
Free cash flow margin——
Net cash / (debt)——
ROIC9.3%—
Return on equity14.9%-58.1%
Gross margin85.4%—
Operating margin25.8%—
Net debt / EBITDA-0.27x0.33x

Figures are as reported by each company; latest fiscal year shown.

Where Regeneron Pharmaceuticals, Inc.'s cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full REGN profile →

Where Revolution Medicines, Inc.'s cash went (FY2025)

Capital spending
$16.0M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full RVMD profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons